New Delhi: DGCI has been approved for the first and second phase of human clinical trials of India’s first COVID-19 vaccine – COVAXIN ™, being developed by Bharat Biotech. This is the first Coronavirus Vaccine vaccine (Coronavirus Vaccine) being prepared in India, which has been approved to be tested on humans. According to the information received, this test will start in July 2020. The company, which manufactures the Kovid-19 vaccine in India, is engaged in efforts to prepare the vaccine in collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV). The SARS-CoV-2 strain was isolated at NIV, Pune and transferred to Bharat Biotech. Indigenous, inactivated vaccines are being developed and manufactured by Bharat Biotech.
American company Johnson & Johnson will also start a human trial of vaccine after two weeks of July. The company is working for human trials two months faster than the earlier schedule. The company has already partnered with the US government to make vaccines. It was told that the company has talked about making 1 billion doses of vaccine. Many UK companies are also doing trials on the corona vaccine, these companies are also preparing to start trials on humans soon.
